BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9098743)

  • 21. Histamine H3 receptor-mediated inhibition of noradrenaline release in the human brain.
    Schlicker E; Werthwein S; Zentner J
    Fundam Clin Pharmacol; 1999; 13(1):120-2. PubMed ID: 10027098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of clobenpropit on regional cerebral blood flow in rat hippocampus.
    Chen Z
    Acta Pharmacol Sin; 2001 Apr; 22(4):355-60. PubMed ID: 11742589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-substituted aryl(thio)ethers as potent partial agonists (or antagonists) for the histamine H3 receptor lacking a nitrogen atom in the side chain.
    Pelloux-Léon N; Fkyerat A; Piripitsi A; Tertiuk W; Schunack W; Stark H; Garbarg M; Ligneau X; Arrang JM; Schwartz JC; Ganellin CR
    J Med Chem; 2004 Jun; 47(12):3264-74. PubMed ID: 15163206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of substance P-induced histamine release from rat peritoneal mast cells by ultraviolet light B irradiation: decreased intracellular calcium as a partial mechanism.
    Amano H; Kurosawa M; Miyachi Y
    Clin Exp Allergy; 1997 Aug; 27(8):966-71. PubMed ID: 9291296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detailed pharmacological characterization of GT-2331 for the rat histamine H3 receptor.
    Ito S; Yoshimoto R; Miyamoto Y; Mitobe Y; Nakamura T; Ishihara A; MacNeil DJ; Kanatani A; Tokita S
    Eur J Pharmacol; 2006 Jan; 529(1-3):40-6. PubMed ID: 16316645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in pharmacological properties of histamine H(3) receptor agonists and antagonists revealed at two human H (3) receptor isoforms.
    Esbenshade TA; Krueger KM; Yao BB; Witte DG; Estvander BR; Baranowski JL; Miller TR; Hancock AA
    Inflamm Res; 2006 Apr; 55 Suppl 1():S45-6. PubMed ID: 16705378
    [No Abstract]   [Full Text] [Related]  

  • 27. H3 autoreceptors modulate histamine synthesis through calcium/calmodulin- and cAMP-dependent protein kinase pathways.
    Torrent A; Moreno-Delgado D; Gómez-Ramírez J; Rodríguez-Agudo D; Rodríguez-Caso C; Sánchez-Jiménez F; Blanco I; Ortiz J
    Mol Pharmacol; 2005 Jan; 67(1):195-203. PubMed ID: 15465923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photolysis of mast cells in presence of protoporphyrin.
    Ranadive NS; Menon IA; Haberman HF
    Acta Derm Venereol; 1979; 59(6):493-7. PubMed ID: 94207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuronal histamine H(3) receptors mediate antisecretory effects in the rat isolated gastric fundus.
    Adami M; Coruzzi G; Guaita E; Schunack W; Kitbunnadaj R; Timmermann H
    Inflamm Res; 2004 Mar; 53 Suppl 1():S25-6. PubMed ID: 15054602
    [No Abstract]   [Full Text] [Related]  

  • 30. The modulatory effects of WE-14 on histamine release from rat peritoneal mast cells.
    Forsythe P; Curry WJ; Johnston CF; Harriott P; MacMahon J; Ennis M
    Inflamm Res; 1997 Mar; 46 Suppl 1():S13-4. PubMed ID: 9098742
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of tannins and related polyphenols on superoxide-induced histamine release from rat peritoneal mast cells.
    Kanoh R; Hatano T; Ito H; Yoshida T; Akagi M
    Phytomedicine; 2000 Jul; 7(4):297-302. PubMed ID: 10969723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulatory effect of (R) alpha-methylhistamine on duodenal HCO3- secretion in anaesthetized rats.
    Coruzzi G; Gambarelli E; Bertaccini G
    Ital J Gastroenterol; 1996 Dec; 28(9):520-2. PubMed ID: 9131398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of MY-1250, a main active metabolite of MY-5116, a new anti-allergic drug, on histamine release from rat peritoneal exudate cells and the degranulation of mesenteric mast cells].
    Takahashi K; Shono T; Arai Y
    Arerugi; 1986 Oct; 35(10):1028-36. PubMed ID: 2434065
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibitions of mast cell-derived histamine release by different Flos Magnoliae species in rat peritoneal mast cells.
    Shen Y; Pang EC; Xue CC; Zhao ZZ; Lin JG; Li CG
    Phytomedicine; 2008 Oct; 15(10):808-14. PubMed ID: 18585022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-imidazole histamine NO-donor H3-antagonists.
    Tosco P; Bertinaria M; Di Stilo A; Cena C; Fruttero R; Gasco A
    Farmaco; 2005; 60(6-7):507-12. PubMed ID: 15927183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Constitutive activity of histamine h(3) receptors stably expressed in SK-N-MC cells: display of agonism and inverse agonism by H(3) antagonists.
    Wieland K; Bongers G; Yamamoto Y; Hashimoto T; Yamatodani A; Menge WM; Timmerman H; Lovenberg TW; Leurs R
    J Pharmacol Exp Ther; 2001 Dec; 299(3):908-14. PubMed ID: 11714875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The histamine H(3) receptor: a target for new drugs].
    Arrang JM
    Ann Pharm Fr; 2003 May; 61(3):173-84. PubMed ID: 12714930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of adenosine and its analogues on histamine release from mast cells.
    Dexter EJ; Butchers PR; Reeves JJ; Sheehan MJ; Pearce FL
    Inflamm Res; 1999 Apr; 48 Suppl 1():S7-8. PubMed ID: 10350137
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of a selection of histone deacetylase inhibitors on mast cell activation and airway and colonic smooth muscle contraction.
    Assem el-SK; Peh KH; Wan BY; Middleton BJ; Dines J; Marson CM
    Int Immunopharmacol; 2008 Dec; 8(13-14):1793-801. PubMed ID: 18805511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for tolerance following repeated dosing in rats with ciproxifan, but not with A-304121.
    Pan JB; Yao BB; Miller TR; Kroeger PE; Bennani YL; Komater VA; Esbenshade TA; Hancock AA; Decker MW; Fox GB
    Life Sci; 2006 Aug; 79(14):1366-79. PubMed ID: 16730751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.